Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor - PubMed (original) (raw)
Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor
Sarah X Zhang et al. FASEB J. 2006 Feb.
Abstract
Pigment epithelium-derived factor (PEDF) is a potent angiogenic inhibitor. Reduced PEDF levels are associated with diabetic retinopathy. However, the mechanism for the protective effects of PEDF against diabetic retinopathy (DR) is presently unclear. As inflammation plays a role in DR, the present study determined the effect of PEDF on inflammation. Western blot analysis and ELISA demonstrated that retinal and plasma PEDF levels were drastically decreased in rats with endotoxin-induced uveitis (EIU), which suggests that PEDF is a negative acute-phase protein. Intravitreal injection of PEDF significantly reduced vascular hyper-permeability in rat models of diabetes and oxygen-induced retinopathy, correlating with the decreased levels of retinal inflammatory factors, including VEGF, VEGF receptor-2, MCP-1, TNF-alpha, and ICAM-1. In cultured retinal capillary endothelial cells, PEDF significantly decreased TNF-alpha and ICAM-1 expression under hypoxia. Moreover, down-regulation of PEDF expression by siRNA resulted in significantly increases of VEGF and TNF-alpha secretion in retinal Müller cells. These findings suggest that PEDF is a novel endogenous anti-inflammatory factor in the eye. The decrease of ocular PEDF levels may contribute to inflammation and vascular leakage in DR.
Similar articles
- Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
Ibrahim AS, Tawfik AM, Hussein KA, Elshafey S, Markand S, Rizk N, Duh EJ, Smith SB, Al-Shabrawey M. Ibrahim AS, et al. Biochim Biophys Acta. 2015 Mar;1851(3):290-8. doi: 10.1016/j.bbalip.2014.12.017. Epub 2015 Jan 3. Biochim Biophys Acta. 2015. PMID: 25562624 Free PMC article. - Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy.
Shen X, Xie B, Cheng Y, Jiao Q, Zhong Y. Shen X, et al. Ocul Immunol Inflamm. 2011 Aug;19(4):246-54. doi: 10.3109/09273948.2011.580073. Ocul Immunol Inflamm. 2011. PMID: 21770802 - Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy.
Elahy M, Baindur-Hudson S, Cruzat VF, Newsholme P, Dass CR. Elahy M, et al. J Endocrinol. 2014 Sep;222(3):R129-39. doi: 10.1530/JOE-14-0065. Epub 2014 Jun 13. J Endocrinol. 2014. PMID: 24928938 Review. - [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
Chmielewska K, Robaszkiewicz J, Kosatka M. Chmielewska K, et al. Klin Oczna. 2008;110(7-9):318-20. Klin Oczna. 2008. PMID: 19112870 Review. Polish.
Cited by
- Pigment Epithelium-Derived Factor Binding to VEGFR-1 (Flt-1) Increases the Survival of Retinal Neurons.
Meng J, Yang XM, Scheer O, Lange J, Müller H, Bürger S, Rothemund S, Younis R, Unterlauft JD, Eichler W. Meng J, et al. Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):27. doi: 10.1167/iovs.65.10.27. Invest Ophthalmol Vis Sci. 2024. PMID: 39167401 Free PMC article. - Cell and molecular targeted therapies for diabetic retinopathy.
Reddy SK, Devi V, Seetharaman ATM, Shailaja S, Bhat KMR, Gangaraju R, Upadhya D. Reddy SK, et al. Front Endocrinol (Lausanne). 2024 Jun 14;15:1416668. doi: 10.3389/fendo.2024.1416668. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38948520 Free PMC article. Review. - Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration.
Wei-Zhang S, Cui B, Xing M, Liu J, Guo Y, He K, Bai T, Dong X, Lei Y, Zhou W, Zhou H, Liu S, Wang X, Zhou D, Yan H. Wei-Zhang S, et al. iScience. 2023 Sep 16;26(10):107939. doi: 10.1016/j.isci.2023.107939. eCollection 2023 Oct 20. iScience. 2023. PMID: 37810255 Free PMC article. - PEDF inhibits LPS-induced acute lung injury in rats and promotes lung epithelial cell survival by upregulating PPAR-γ.
Xu L, Chen Y, Feng S, Liu Z, Ye Y, Zhou R, Liu L. Xu L, et al. BMC Pulm Med. 2023 Sep 23;23(1):359. doi: 10.1186/s12890-023-02666-3. BMC Pulm Med. 2023. PMID: 37740176 Free PMC article. - Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.
Qu Q, Park K, Zhou K, Wassel D, Farjo R, Criswell T, Ma JX, Zhang Y. Qu Q, et al. Front Cell Dev Biol. 2022 Dec 16;10:1049678. doi: 10.3389/fcell.2022.1049678. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36589744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous